by Marina Zhang | Dec 8, 2023 | Uncategorized
On Friday, the U.S. Food and Drug Administration (FDA) approved CRISPR and lentiviral vector-based gene therapies for treating sickle cell disease in patients aged 12 years or older. “Today’s actions follow rigorous evaluations of the scientific and clinical data...
by Marina Zhang | Dec 1, 2023 | Uncategorized
Insomnia and melatonin supplementation are not words one would often associate with children. But recent survey findings published in the Journal of the American Medical Association (JAMA) Pediatrics suggest that melatonin consumption in U.S. children and adolescents...